Lialda Alternatives Compared
Lialda | Entyvio | Stelara |
|
---|
Lialda (mesalamine) | Entyvio (vedolizumab) | Stelara (ustekinumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Ulcerative Colitis - Maintenance, Ulcerative Colitis - Active, Ulcerative Proctitis, Inflammatory Bowel Disease, Ulcerative Colitis. Lialda may also be used for purposes not listed in... View more |
Prescription only
Entyvio infusion is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically... View more |
Prescription only
Stelara is an immunosuppressant medication that works by binding to two inflammatory cytokines, IL-12 and IL-23, which have been identified as important contributors to chronic inflammation. Stelara... View more |
Related suggestions Ulcerative Colitis
|
|||||||||||||||||||||||
More about Lialda (mesalamine) | More about Entyvio (vedolizumab) | More about Stelara (ustekinumab) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Lialda has an average rating of 7.0 out of 10 from a total of 105 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. |
Entyvio has an average rating of 6.2 out of 10 from a total of 158 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 28% reported a negative effect. |
Stelara has an average rating of 7.6 out of 10 from a total of 244 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Lialda side effects in more detail. |
See also: Entyvio side effects in more detail. |
See also: Stelara side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Lialda prices |
View all Entyvio prices |
View all Stelara prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other mesalamine brands include: Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Pentasa, Rowasa, Rowasa Sulfite Free, Zaldyon View more | Other vedolizumab brands include: Entyvio Pen | Other ustekinumab brands include: Pyzchiva, Selarsdi, Wezlana | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
10 hours |
600 hours |
1291.2 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 120 drugs are known to interact with Lialda:
|
A total of 146 drugs are known to interact with Entyvio:
|
A total of 453 drugs are known to interact with Stelara:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
January 16, 2007 |
May 20, 2014 |
September 25, 2009 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.